CN-105 in Acute Supratentorial ICH Trial: A Phase 2b, Randomised Controlled Trial
Publication
, Conference
Cheong, TM; James, ML; Poh, Y; Ng, V; Laskowitz, D
Published in: CEREBROVASCULAR DISEASES
2025
Duke Scholars
Published In
CEREBROVASCULAR DISEASES
EISSN
1421-9786
ISSN
1015-9770
Publication Date
2025
Volume
54
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Cheong, T. M., James, M. L., Poh, Y., Ng, V., & Laskowitz, D. (2025). CN-105 in Acute Supratentorial ICH Trial: A Phase 2b, Randomised Controlled Trial. In CEREBROVASCULAR DISEASES (Vol. 54).
Cheong, Tien Meng, Michael Luke James, Yew Poh, Vincent Ng, and Daniel Laskowitz. “CN-105 in Acute Supratentorial ICH Trial: A Phase 2b, Randomised Controlled Trial.” In CEREBROVASCULAR DISEASES, Vol. 54, 2025.
Cheong TM, James ML, Poh Y, Ng V, Laskowitz D. CN-105 in Acute Supratentorial ICH Trial: A Phase 2b, Randomised Controlled Trial. In: CEREBROVASCULAR DISEASES. 2025.
Cheong, Tien Meng, et al. “CN-105 in Acute Supratentorial ICH Trial: A Phase 2b, Randomised Controlled Trial.” CEREBROVASCULAR DISEASES, vol. 54, 2025.
Cheong TM, James ML, Poh Y, Ng V, Laskowitz D. CN-105 in Acute Supratentorial ICH Trial: A Phase 2b, Randomised Controlled Trial. CEREBROVASCULAR DISEASES. 2025.
Published In
CEREBROVASCULAR DISEASES
EISSN
1421-9786
ISSN
1015-9770
Publication Date
2025
Volume
54
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences